RhumbLine Advisers’s Tenaya Therapeutics TNYA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-69,193
| Closed | -$39.4K | – | 4262 |
|
|
2025
Q1 | $39.4K | Sell |
69,193
-11,493
| -14% | -$6.55K | ﹤0.01% | 3625 |
|
|
2024
Q4 | $115K | Buy |
80,686
+1,087
| +1% | +$1.55K | ﹤0.01% | 3437 |
|
|
2024
Q3 | $154K | Buy |
79,599
+1,439
| +2% | +$2.78K | ﹤0.01% | 3352 |
|
|
2024
Q2 | $242K | Buy |
78,160
+7,441
| +11% | +$23.1K | ﹤0.01% | 3119 |
|
|
2024
Q1 | $370K | Buy |
70,719
+2,233
| +3% | +$11.7K | ﹤0.01% | 2846 |
|
|
2023
Q4 | $222K | Buy |
68,486
+476
| +0.7% | +$1.54K | ﹤0.01% | 3129 |
|
|
2023
Q3 | $173K | Hold |
68,010
| – | – | ﹤0.01% | 3233 |
|
|
2023
Q2 | $399K | Buy |
68,010
+3,038
| +5% | +$17.8K | ﹤0.01% | 2835 |
|
|
2023
Q1 | $185K | Buy |
64,972
+22,509
| +53% | +$64.1K | ﹤0.01% | 2753 |
|
|
2022
Q4 | $85K | Buy |
42,463
+141
| +0.3% | +$282 | ﹤0.01% | 2916 |
|
|
2022
Q3 | $123K | Buy |
42,322
+2,307
| +6% | +$6.71K | ﹤0.01% | 2981 |
|
|
2022
Q2 | $225K | Buy |
40,015
+17,217
| +76% | +$96.8K | ﹤0.01% | 2890 |
|
|
2022
Q1 | $269K | Buy |
22,798
+12,646
| +125% | +$149K | ﹤0.01% | 2676 |
|
|
2021
Q4 | $192K | Sell |
10,152
-70
| -0.7% | -$1.32K | ﹤0.01% | 2843 |
|
|
2021
Q3 | $211K | Buy |
+10,222
| New | +$211K | ﹤0.01% | 2898 |
|